[Immunomorphological evaluation of cholesteatoma].
Molecular and cellular mechanisms in chronic otitis media (COM) with cholesteatoma have not been clearly enough known so far. Investigations on cholesteatoma are focused on its immunological and morphological status. The authors presented the results of immunomorphological evaluation of 31 patients with COM with cholesteatoma, divided into three groups. In the first group there were 4 patients with congenital cholesteatoma, in the second group 19 patient with primary acquired cholesteatoma and in the third group 8 patient with secondary acquired cholesteatoma. Immunohistochemical investigations were performed using antibodies for identification the tenascin, S-100 protein, antigens Ki 67, CD 31, FVIII, HLA-DR, and growth factors TGFbeta1 and EGFR. The immunological activity was assessed for three types and matrix and perimatrix of cholesteatoma. High expression of tenascin was proven in the perimatrix of cholesteatoma and protein S-100 was highly expressed in the cholesteatoma matrix. Ki 67 antigen was seen rarely and mostly was present in basal cells of the matrix. The presence of endothelial cells was proven mainly in the connective and vascular tissue of perimatrix (CD 31, FVIII). The high expression of HLA-DR in matrix confirms the presence of Langerhans cells. The presence of growth factors TGFbeta1 and EGFR was observed in peribasal layer of the epithelium and keratinocytes of cholesteatoma matrix. Activity of immunological processes in COM with cholesteatoma confirms their important role in pathophysiology of chronic otitis media with cholesteatoma.
Katedra i Klinika Chorób Uszu, Nosa, Gardła i Krtani AM w Gdańsku. jerzyk@amedec.amg.gda.pl
Jerzy
J
Kuczkowski
Alicja
A
Bakowska
Bogusław
B
Mikaszewski
D000293:Adolescent; D000328:Adult; D000911:Antibodies, Monoclonal / Q000032:analysis*; D002648:Child; D002675:Child, Preschool; D018424:Cholesteatoma, Middle Ear / Q000276:immunology / Q000473:pathology*; D066246:ErbB Receptors / Q000032:analysis; D005260:Female; D006684:HLA-DR Antigens / Q000032:analysis; D006801:Humans; D007150:Immunohistochemistry; D019394:Ki-67 Antigen / Q000032:analysis; D008297:Male; D008875:Middle Aged; D010033:Otitis Media / Q000276:immunology / Q000473:pathology*; D019408:Platelet Endothelial Cell Adhesion Molecule-1 / Q000032:analysis; D011044:Poland; D009418:S100 Proteins / Q000032:analysis; D019063:Tenascin / Q000032:analysis; D016212:Transforming Growth Factor beta / Q000032:analysis; D014841:von Willebrand Factor / Q000032:analysis
D000911:Antibodies, Monoclonal; D006684:HLA-DR Antigens; D019394:Ki-67 Antigen; D019408:Platelet Endothelial Cell Adhesion Molecule-1; D009418:S100 Proteins; D019063:Tenascin; D016212:Transforming Growth Factor beta; D014841:von Willebrand Factor; D066246:ErbB Receptors